Back to overview

3-year Industrial Postdoc Fellowship awarded to Lluís Riera-Ponsatí

This grant from the Innovation Fund Denmark (IFD) will help us in further establishing our drug discovery pipeline, aimed at developing disease-modifying RNA Therapies for Parkinson's Disease at NEUmiRNA, in collaboration with Aalborg University and the Center for RNA Medicine (CRM).
Development
Funding

Related topics

Development
29.4.2026
Dr. Ferenc Tracik Joins Neumirna as Chief Medical Officer
We are excited to announce the appointment of Dr. Ferenc Tracik as Neumirna’s Chief Medical Officer (CMO).
Read full article
Funding
Publication
27.3.2026
Meet Neumirna at Conferences and Events in 2026
Find out where you can connect with our team this year
Read full article
Development
Publication
12.1.2026
Neumirna at AES: new data on NMT.001
At the American Epilepsy Society Annual Meeting, Neumirna presented two posters highlighting the potential of its RNA-based approach for drug-resistant epilepsy.
Read full article